Shots:

• SMA Foundation and PTC will provide an initial investment of up to $60M in research to discover & develop regenerative treatments in neuromuscular diseases
• The focus of the agreement is advance scientific research in SMA and other neuromuscular disorders to develop new treatments
• The availability of several disease-modifying therapies has made regenerative interventions the next frontier in drug discovery and development

 ­ Ref: PRNewswire | Image: Wikipedia